These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36609820)

  • 1. Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review.
    Johnson TM; Byrd TF; Drummond WK; Childs-Kean LM; Mahoney MV; Pearson JC; Rivera CG
    Infect Dis Ther; 2023 Feb; 12(2):343-365. PubMed ID: 36609820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens:
    To K; Cao R; Yegiazaryan A; Owens J; Venketaraman V
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32781595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.
    Martiniano SL; Wagner BD; Levin A; Nick JA; Sagel SD; Daley CL
    Chest; 2017 Oct; 152(4):800-809. PubMed ID: 28483608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-Specific Risk Factors, Treatment Decisions, and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State.
    Ford ES; Horne DJ; Shah JA; Wallis CK; Fang FC; Hawn TR
    Ann Am Thorac Soc; 2017 Jul; 14(7):1129-1138. PubMed ID: 28387523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.
    Yoon HJ; Choi HY; Ki M
    BMC Infect Dis; 2017 Jun; 17(1):432. PubMed ID: 28619015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure among Patients with Non-Tuberculous Mycobacterial Infections in Skin, Soft Tissue, and Musculoskeletal System in Southern Taiwan, 2012-2015.
    Hsueh JH; Fang SY; Hsieh YH; Chen LW; Lee SS
    Surg Infect (Larchmt); 2019 Sep; 20(6):492-498. PubMed ID: 31066636
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
    Ruth MM; Koeken VACM; Pennings LJ; Svensson EM; Wertheim HFL; Hoefsloot W; van Ingen J
    J Antimicrob Chemother; 2020 Mar; 75(3):609-617. PubMed ID: 31886864
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections.
    Banaschewski B; Verma D; Pennings LJ; Zimmerman M; Ye Q; Gadawa J; Dartois V; Ordway D; van Ingen J; Ufer S; Stapleton K; Hofmann T
    J Cyst Fibros; 2019 Sep; 18(5):714-720. PubMed ID: 31138497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 40-Year-Old Female With Mycobacterium abscessus Successfully Treated With a Dual Beta-Lactam Combination.
    Moguillansky N; DeSear K; Dousa KM
    Cureus; 2023 Jun; 15(6):e40993. PubMed ID: 37503487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 14. Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review.
    Lee MR; Chang LY; Ko JC; Wang HC; Huang YW
    J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S4-S12. PubMed ID: 32482605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2022 Dec; 43(4):697-716. PubMed ID: 36344075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for nontuberculous mycobacterial pulmonary disease.
    Velagapudi M; Sanley MJ; Ased S; Destache C; Malesker MA
    Am J Health Syst Pharm; 2022 Mar; 79(6):437-445. PubMed ID: 34788375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections.
    Li W; Yazidi A; Pandya AN; Hegde P; Tong W; Calado Nogueira de Moura V; North EJ; Sygusch J; Jackson M
    Front Microbiol; 2018; 9():1547. PubMed ID: 30042757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nontuberculous mycobacterial pulmonary infections.
    Johnson MM; Odell JA
    J Thorac Dis; 2014 Mar; 6(3):210-20. PubMed ID: 24624285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of amikacin in the treatment of nontuberculous mycobacterial disease.
    Raaijmakers J; Schildkraut JA; Hoefsloot W; van Ingen J
    Expert Opin Pharmacother; 2021 Oct; 22(15):1961-1974. PubMed ID: 34292097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.